FSRH CEU Statement: Contraception for women using known teratogenic drugs or drugs with potential teratogenic effects - (February 2018)

Published on: 14 February 2018

File size: 241kb PDF

File type: Clinical Statements

This statement provides guidance on contraceptive options for women taking (or whose male partners are taking) known teratogenic drugs or drugs with potential teratogenic effects. Download the full document and save.

Your download should start automatically. If not download directly.